Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-19

FDA Approved: MEMANTINE — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for memantine submitted by NorthStar RxLLC (ANDA090048).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MEMANTINE HYDROCHLORIDE (Memantine hydrochloride)
  • Memantine (memantine)

Snippet

SUPPL AP for MEMANTINE (MEMANTINE)